Investor Gong Hongjia has seen his wealth rise significantly through strategic investments in notable companies. A key move was his acquisition of a 49% stake in Tecsun and Hikvision. The public listing of Hikvision, a prominent supplier of surveillance products, boosted his net worth to an impressive $13 billion.
Gong’s involvement with Hikvision has been a cornerstone of his financial success. He served as Hikvision’s vice chairman until 2021 and remains its largest individual shareholder. This role has cemented his position as a major player in the technology and surveillance industry.
In addition to his technology investments, Gong is actively involved in Hong Kong’s real estate market. He has made substantial investments in the sector, contributing to his diversified portfolio. Despite his significant business activities, Gong maintains a low profile, living a private life with his family in Hong Kong.
Beyond Hikvision, Gong’s business interests extend to biotechnology. He chairs Vcanbio Cell & Gene Engineering, a Shanghai-listed company focused on the preparation, detection, and storage of stem cells. This role reflects his interest in innovative and future-oriented industries.
In December 2022, Gong expanded his investment portfolio by acquiring a 2.4% stake in C-Mer Eye Care Holdings. This Chinese medical services provider is known for its specialized eye care services. This investment aligns with Gong’s strategy of diversifying into various sectors, including healthcare.
Gong Hongjia holds permanent residency in Hong Kong, a status that supports his business activities and personal lifestyle. His strategic investments and diversified portfolio have solidified his position as a prominent figure in both the technology and real estate sectors.
